UBS Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

UBS Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-166,438	Closed	-$2.62M	–	8993
2024 Q1	$2.62M	Buy	166,438 +40,115	+32%	+$631K	﹤0.01%	2743
2023 Q4	$2.04M	Buy	126,323 +68,064	+117%	+$1.1M	﹤0.01%	2836
2023 Q3	$741K	Sell	58,259 -31,133	-35%	-$396K	﹤0.01%	3332
2023 Q2	$1.26M	Sell	89,392 -6,004	-6%	-$84.5K	﹤0.01%	3100
2023 Q1	$1.47M	Sell	95,396 -73,944	-44%	-$1.14M	﹤0.01%	2859
2022 Q4	$2.78M	Buy	169,340 +128,397	+314%	+$2.1M	﹤0.01%	2293
2022 Q3	$758K	Sell	40,943 -62,611	-60%	-$1.16M	﹤0.01%	3053
2022 Q2	$1.36M	Sell	103,554 -308,424	-75%	-$4.06M	﹤0.01%	2652
2022 Q1	$3.82M	Sell	411,978 -34,401	-8%	-$319K	﹤0.01%	2141
2021 Q4	$4.36M	Buy	446,379 +415,783	+1,359%	+$4.06M	﹤0.01%	2214
2021 Q3	$1.04M	Buy	30,596 +20,401	+200%	+$693K	﹤0.01%	3236
2021 Q2	$373K	Sell	10,195 -30,866	-75%	-$1.13M	﹤0.01%	3942
2021 Q1	$1.84M	Buy	41,061 +19,254	+88%	+$864K	﹤0.01%	2835
2020 Q4	$1.25M	Buy	21,807 +2,323	+12%	+$133K	﹤0.01%	2995
2020 Q3	$1M	Buy	19,484 +5,172	+36%	+$265K	﹤0.01%	2919
2020 Q2	$855K	Buy	14,312 +11,367	+386%	+$679K	﹤0.01%	2945
2020 Q1	$121K	Sell	2,945 -7,109	-71%	-$292K	﹤0.01%	4272
2019 Q4	$625K	Sell	10,054 -46,875	-82%	-$2.91M	﹤0.01%	3717
2019 Q3	$1.93M	Buy	56,929 +46,172	+429%	+$1.57M	﹤0.01%	2636
2019 Q2	$243K	Buy	10,757 +2,927	+37%	+$66.1K	﹤0.01%	3989
2019 Q1	$182K	Sell	7,830 -41,273	-84%	-$959K	﹤0.01%	3900
2018 Q4	$1.03M	Buy	49,103 +43,892	+842%	+$922K	﹤0.01%	2970
2018 Q3	$202K	Sell	5,211 -1,128	-18%	-$43.7K	﹤0.01%	4225
2018 Q2	$250K	Buy	6,339 +1,659	+35%	+$65.4K	﹤0.01%	3960
2018 Q1	$94K	Buy	4,680 +273	+6%	+$5.48K	﹤0.01%	4429
2017 Q4	$100K	Buy	+4,407	New	+$100K	﹤0.01%	4419